Adalimumab

Adalimumab is used in the treatment of ankylosing spondylitis, rheumatoid arthritis, psoriasis, Ulcerative colitis and Crohn’s disease.

Adalimumab blocks the action of certain chemical messengers that are responsible for inflammation, swelling and redness associated with certain joint diseases.

Sinus inflammation, Upper respiratory tract infection, Injection site reactions (pain, swelling, redness), Infection